Back to Treatments

Treatment

Naltrexone (low-dose)

1
Conditions
3
Trials
750
Participants
80%
Average Safety

Condition Evidence

Chronic Fatigue Syndrome

3 trials · 750 participants

55% effectiveness · 80% safety
Naltrexone (low-dose) | DFDA